ID   MPSC1
AC   CVCL_9822
SY   MPSC 1
DR   Cosmic; 906589
DR   Wikidata; Q54906520
RX   PubMed=15753399;
RX   PubMed=23415752;
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
RX   PubMed=15753399; DOI=10.1158/0008-5472.CAN-04-3625;
RA   Pohl G., Ho C.-L., Kurman R.J., Bristow R., Wang T.-L., Shih I.-M.;
RT   "Inactivation of the mitogen-activated protein kinase pathway as a
RT   potential target-based therapy in ovarian serous tumors with KRAS or
RT   BRAF mutations.";
RL   Cancer Res. 65:1994-2000(2005).
//
RX   PubMed=23415752; DOI=10.1016/j.molonc.2012.12.007; PMCID=PMC4106023;
RA   Stordal B., Timms K., Farrelly A., Gallagher D., Busschots S.,
RA   Renaud M., Thery J., Williams D., Potter J., Tran T., Korpanty G.,
RA   Cremona M., Carey M.S., Li J., Li Y., Aslan O., O'Leary J.J.,
RA   Mills G.B., Hennessy B.T.;
RT   "BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one
RT   functionally deleterious BRCA1 mutation.";
RL   Mol. Oncol. 7:567-579(2013).
//